Santhosh Vadivelu (@science2cure) profile picture

Santhosh Vadivelu

@science2cure

Inventor, Entrepreneur, Recovering Venture capitalist, ex-Biopharm exec, immigrant, CEO, Board Member

 Boston, MA
Joined April 2009
  • Tweets10
  • Following57
  • Followers40
Santhosh Vadivelu retweeted
Bruce Booth (@LifeSciVC) profile picture
Bruce Booth
@LifeSciVC8 May 2021
Global leadership from @Pfizer’s Bourla: important letter about #COVID vaccine access and IP. New mantra: “Science Will Win (Unless Politics Gets In The Way)”
Albert Bourla (@AlbertBourla) profile pictureAlbert Bourla
@AlbertBourla7 May 2021
Candor makes us stronger. Today I sent this letter to @Pfizer colleagues to discuss transparently truths and facts about our #COVID19 vaccine access and availability. linkedin.com/pulse/today-i-s…
Today I Sent This Letter To Have a Candid Conversation With Our Colleagues About the Drivers of...

Today I Sent This Letter To Have a Candid Conversation With Our Colleagues About the Drivers of...

Dear Colleagues, The recent announcement that the United States Trade Representative will discuss options to waive some COVID-19 vaccine intellectual property (IP) rights has created some confusion...

linkedin.com
5
51
Santhosh Vadivelu retweeted
Wende Hutton (@WendeHutton) profile picture
Wende Hutton@WendeHutton24 Feb 2021
A milestone in targeted oncology and looking ahead canaan.com/latest/a-mileston… via @canaanpartners
A milestone in targeted oncology and looking ahead - Canaan

A milestone in targeted oncology and looking ahead - Canaan

In honor of this historic event, we want to share a few thoughts about the future of targeted oncology and where we are making investments at Canaan.

canaan.com
2
6
Santhosh Vadivelu retweeted
Julie Papanek Grant (@JuliePapanek) profile picture
Julie Papanek Grant@JuliePapanek7 Jul 2020
The #1 topic on my mind as an investor is child care. It is the top issue from CEOs, c-suite execs and employees at all levels. No schools = no employees, nurses, essential workers++. Seeking solutions small business can legally implement. Contact me apple.news/A5YobaIyJSiSWokKP…

The big factor holding back the U.S. economic recovery: Child care

Nearly a third of the nation’s workforce has children at home and they’re struggling. Researchers estimate nearly 10 percent of economic activity won’t happen as long as schools and daycares remain...

apple.news
1
1
27
‘Some countries talked about herd immunity as a strategy. In New Zealand we never ever considered that. Herd immunity would have meant 10s of 10000s of New Zealanders dying & I simply would not have tolerated that’ Today New Zealand returns to work teapawt.net/BorisJohnson_MP/status…
485
7,607
1,116
23,649
Santhosh Vadivelu retweeted
Wende Hutton (@WendeHutton) profile picture
Wende Hutton@WendeHutton14 Apr 2020
What Do Countries With The Best Coronavirus Responses Have In Common? Women Leaders via @forbes forbes.com/sites/avivahwitte…
8
2
22
Santhosh Vadivelu retweeted
Bruce Booth (@LifeSciVC) profile picture
Bruce Booth
@LifeSciVC24 Mar 2020
In mild COVID-19 patients, placebo was similarly effective to HCQ in viral clearance. Randomized open label clinical trial (NCT04261517): in 30 mild patients, 93% cleared virus w/in 7 days on placebo (vs 87% with HCQ). h/t Umer Raffat at EvercoreISI
26
141
51
318
Thoughtful thread on bringing clinically meaningful therapies worldwide
Nina Kjellson (@nkjellson) profile pictureNina Kjellson@nkjellson24 Sep 2019
Cell therapies are life-changing for people living with cancer. But should money be a barrier to miracle drugs? As science races forward, it’s time to have a tough conversation about how we pay for CAR-T treatments. Otherwise, what good are they? 1/
Santhosh Vadivelu retweeted
Sara Nayeem (@SaraNayeem) profile picture
Sara Nayeem
@SaraNayeem19 Aug 2019
Wow - pretty stunning. Is it because biopharma co’s prefer to fly under the radar? Are too science-y to be of broader interest? Laziness on the part of journalists? Hard to ignore the massive scientific advances we’ve had in recent years - I-O, gene /mRNA therapy, gene editing...
Matthew Herper (@matthewherper) profile pictureMatthew Herper
@matthewherper19 Aug 2019
Another metric re: biopharma's bad PR. Fortune's list of companies changing the world includes Illumina and Impossible, but not a single company developing new treatments for disease. fortune.com/change-the-world…
2
2
4
Santhosh Vadivelu retweeted
David Berry (@DavidBerry26) profile picture
David Berry
@DavidBerry266 Jul 2019
Pharma's plan to improve productivity? More mergers...wont be surprised when this means more job cuts and program cuts. wsj.com/articles/plan-on-mor…
Plan on More Pharma Megamergers

Plan on More Pharma Megamergers

Tough R&D conditions and backlash over high drug prices have put megamergers back on the agenda for biotech and pharma companies desperate for growth.

wsj.com
1
2
Santhosh Vadivelu retweeted
Canaan (@canaanpartners) profile picture
Canaan@canaanpartners10 Oct 2018
.@mahaibrahim’s advice to founders? “Founders make sacrifices   that most of us cannot imagine. It is a hard, lonely journey. The idea/mission of your company should mean more than just something to you; it should mean everything to you.” medium.com/startup-grind/vc-…
2
6
Load more